Home › Funds › D. E. Shaw & Co › GRDN
D. E. Shaw & Co position in GRDN
GUARDIAN PHARMACY SVCS INC · Consumer Staples
Latest position (Q2 2026)73.84K sh
Reported value held$3.09M
Portfolio Weight0.00%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 46.55K | $1.22M | New |
| Q4 2025 | 86.53K | $2.60M | Add |
| Q1 2026 | 75.68K | $2.85M | Reduce |
| Q2 2026 | 73.84K | $3.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GRDN
- Fidelity Management & Research (FMR) 3.24M sh · $135.73M · Q2 2026
- Wellington Management Group 1.73M sh · $72.39M · Q2 2026
- BlackRock Inc 1.58M sh · $65.99M · Q2 2026
- Vanguard Group 1.35M sh · $40.73M · Q4 2025
- Franklin Resources 966.21K sh · $40.46M · Q2 2026
- Geode Capital Management 646.70K sh · $27.08M · Q2 2026
- Morgan Stanley 312.00K sh · $13.06M · Q2 2026
- Northern Trust Corp 211.38K sh · $8.85M · Q2 2026
- Goldman Sachs Group 171.69K sh · $7.19M · Q2 2026
- Lazard Asset Management 169.53K sh · $7.10M · Q2 2026
- Bank of America Corp 163.17K sh · $6.83M · Q2 2026
- Millennium Management 120.61K sh · $5.05M · Q2 2026